199 BIOTECHNOLOGIES LTD

Company Registration Number:
14736867 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2024

Period of accounts

Start date: 17 March 2023

End date: 31 March 2024

199 BIOTECHNOLOGIES LTD

Contents of the Financial Statements

for the Period Ended 31 March 2024

Company Information - 3
Report of the Directors - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

199 BIOTECHNOLOGIES LTD

Company Information

for the Period Ended 31 March 2024




Director: Boris Djordjevic
Registered office: 199
Gloucester Terrace
London
England
W2 6LD
Company Registration Number: 14736867 (England and Wales)

199 BIOTECHNOLOGIES LTD

Directors' Report Period Ended 31 March 2024

The directors present their report with the financial statements of the company for the period ended 31 March 2024

Principal Activities

Being research and experimental development on biotechnology.

Political and charitable donations

Not applicable.

Company policy on the employment of disabled persons

Not applicable.

Directors

The director(s) shown below were appointed to the company during the period
Boris Djordjevic
17 March 2023

This report was approved by the board of directors on 3 January 2025
And Signed On Behalf Of The Board By:

Name: Boris Djordjevic
Status: Director

199 BIOTECHNOLOGIES LTD

Balance sheet

As at 31 March 2024


2024
£
Called up share capital not paid: 0
Fixed Assets: 1,641,327
Current assets: 76,910
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: ( 350,419 )
Net current assets (liabilities): ( 273,509 )
Total assets less current liabilities: 1,367,818
Total net assets (liabilities): 1,367,818
Capital and reserves: 1,367,818

199 BIOTECHNOLOGIES LTD

Balance sheet continued

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 3 January 2025
And Signed On Behalf Of The Board By:

Name: Boris Djordjevic
Status: Director

The notes form part of these financial statements

199 BIOTECHNOLOGIES LTD

Footnotes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Employee Information

    Average number of employees: 8

199 BIOTECHNOLOGIES LTD

Footnotes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Off balance sheet disclosure

    No